Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adeline Vulin

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2009
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activityHelge Amthor, Anthony Otto, Adeline Vulin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 13, 2012
Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skippingAdeline Vulin, Inès Barthélémy, Aurélie Goyenvalle, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2022
Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouseNicolas Wein, Tatyana A Vetter, Adeline Vulin, et al.
Human Mutation|December 5, 2013
The ZZ domain of dystrophin in DMD: making sense of missense mutationsAdeline Vulin, Nicolas Wein, Dana M Strandjord, et al.
Skeletal Muscle|August 10, 2020
X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisationInès Barthélémy, Nadège Calmels, Robert B Weiss, et al.
Neurology|October 31, 2014
Dystrophin quantification: Biological and translational research implicationsKaren Anthony, Virginia Arechavala-Gomeza, Laura E Taylor, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 8, 2011
Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skippingLawrence T Bish, Meg M Sleeper, Sean C Forbes, et al.
Nature Medicine|April 8, 2015
Corrigendum: Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and miceNicolas Wein, Adeline Vulin, Maria S Falzarano, et al.
Nature Medicine|August 11, 2014
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and miceNicolas Wein, Adeline Vulin, Maria S Falzarano, et al.
Nature Medicine|May 8, 2015
Corrigendum: Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and miceNicolas Wein, Adeline Vulin, Maria S Falzarano, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2009
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activityHelge Amthor, Anthony Otto, Adeline Vulin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 13, 2012
Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skippingAdeline Vulin, Inès Barthélémy, Aurélie Goyenvalle, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2022
Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouseNicolas Wein, Tatyana A Vetter, Adeline Vulin, et al.
Human Mutation|December 5, 2013
The ZZ domain of dystrophin in DMD: making sense of missense mutationsAdeline Vulin, Nicolas Wein, Dana M Strandjord, et al.
Skeletal Muscle|August 10, 2020
X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisationInès Barthélémy, Nadège Calmels, Robert B Weiss, et al.
Neurology|October 31, 2014
Dystrophin quantification: Biological and translational research implicationsKaren Anthony, Virginia Arechavala-Gomeza, Laura E Taylor, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 8, 2011
Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skippingLawrence T Bish, Meg M Sleeper, Sean C Forbes, et al.
Nature Medicine|April 8, 2015
Corrigendum: Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and miceNicolas Wein, Adeline Vulin, Maria S Falzarano, et al.
Nature Medicine|August 11, 2014
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and miceNicolas Wein, Adeline Vulin, Maria S Falzarano, et al.
Nature Medicine|May 8, 2015
Corrigendum: Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and miceNicolas Wein, Adeline Vulin, Maria S Falzarano, et al.
Pageof 3